Related references
Note: Only part of the references are listed.Synthesis, cytotoxicity, and molecular docking of methylated (-)-epigallocatechin-3-gallate-4β-triazolopodophyllotoxin derivatives as novel antitumor agents
Cheng-Ting Zi et al.
JOURNAL OF CHEMICAL RESEARCH (2021)
Advances in phytochemical delivery systems for improved anticancer activity
Ricardo Lagoa et al.
BIOTECHNOLOGY ADVANCES (2020)
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
Tan Boon Toh et al.
JOURNAL OF HEPATOLOGY (2020)
Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling
Yue Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway
Shuang Zhao et al.
LIFE SCIENCES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Telomeres and Telomerase in the Development of Liver Cancer
Lena in der Stroth et al.
CANCERS (2020)
Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway
Ye Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Novel molecular targets in hepatocellular carcinoma
Ariel Ka-Man Chow et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)
The red pepper's spicy ingredient capsaicin activates AMPK in HepG2 cells through CaMKKβ
Alicia Bort et al.
PLOS ONE (2019)
Crocin, a carotenoid, suppresses spindle microtubule dynamics and activates the mitotic checkpoint by binding to tubulin
Avishkar V. Sawant et al.
BIOCHEMICAL PHARMACOLOGY (2019)
In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
Wang Wang et al.
MOLECULES (2019)
Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
Amna Parveen et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
Cristian Scheau et al.
MOLECULES (2019)
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma
Xiangkun Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation
Lei Song et al.
MOLECULAR MEDICINE REPORTS (2019)
Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer
Nannan Li et al.
MOLECULES (2019)
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells
Won-Chul Lim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis
Georg Wiltberger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer
Chunpu Li et al.
BIOMATERIALS SCIENCE (2019)
Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway
Jia Xiao et al.
ACTA PHARMACEUTICA SINICA B (2018)
Phenolic contents, cellular antioxidant activity and antiproliferative capacity of different varieties of oats
Chao Chen et al.
FOOD CHEMISTRY (2018)
Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma
Fang Wang et al.
HEPATOLOGY (2018)
Exosomal miRNAs in hepatocellular carcinoma development and clinical responses
Shuangshuang Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Chun-Ming Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells
Buyun Kim et al.
ONCOLOGY REPORTS (2018)
Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1
Wei-Ting Chen et al.
PLOS ONE (2018)
Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity
Chong Yao et al.
ONCOTARGETS AND THERAPY (2018)
Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells
Ala'a Al-Hrout et al.
SCIENTIFIC REPORTS (2018)
Immunomodulation in hepatocellular cancer
Sunyoung Lee et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
Gail M. Wilkes
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2018)
Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling
Su-shan Zhang et al.
ACTA PHARMACOLOGICA SINICA (2018)
Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma
Jie Tang et al.
MINERVA MEDICA (2018)
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Masatoshi Kudo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Development of a therapeutic model of precancerous liver using crocin-coated magnetite nanoparticles
Rkia El-Kharrag et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway
Huanhuan Chen et al.
ONCOLOGY REPORTS (2017)
Cabozantinib in the treatment of hepatocellular carcinoma
Mary Linton B. Peters et al.
FUTURE ONCOLOGY (2017)
Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation
Rejina Afrin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma
Honglei Jiang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway
Yu-Tsai Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo
Yuan Yan et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor β-activated kinase 1
Yiming Chen et al.
MOLECULAR MEDICINE REPORTS (2017)
Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells
Xiaojie Huang et al.
PROTEIN AND PEPTIDE LETTERS (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells
Orawan Wonganan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth
Hao Yang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
Fangfang Jin et al.
CELL DEATH & DISEASE (2017)
HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs
Li Xiong et al.
ONCOLOGY LETTERS (2017)
Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
Alicia Bort et al.
ONCOTARGET (2017)
Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway
Gang Xu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways
Mhmoud Youns et al.
PLOS ONE (2017)
In vitro, In silico and In vivo Antitumor Activity of Crude Methanolic Extract of Tetilla dactyloidea (Carter, 1869) on DEN Induced HCC in a Rat Model
Gowri Shankar Krishnan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo
Lin Liu et al.
CANCER BIOLOGY & THERAPY (2017)
Scutellarein antagonizes the tumorigenesis by modulating cytokine VEGF mediated neoangiogenesis and DFF-40 actuated nucleosomal degradation
Prabhu Thirusangu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways
Ratana Banjerdpongchai et al.
TUMOR BIOLOGY (2016)
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)aEuro
D. Koeberle et al.
ANNALS OF ONCOLOGY (2016)
Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit
Min Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle
Ziyou Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin-induced apoptosis in human hepatocellular carcinoma cells
Xun Chen et al.
FREE RADICAL RESEARCH (2016)
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
Ann-Lii Cheng et al.
HEPATOLOGY (2016)
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
Jessica L. Petrick et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Chrysin, Abundant in Morinda citrifolia Fruit Water-EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells
Cheng Huang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses
Victor Fattori et al.
MOLECULES (2016)
Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Amr Amin et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2016)
Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice
Subhayan Sur et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis
Le Shi et al.
TUMOR BIOLOGY (2016)
Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma
Jianping Shao et al.
ONCOTARGETS AND THERAPY (2016)
(-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma
Tiemin Pei et al.
ONCOTARGET (2016)
Defect engineering of two-dimensional transition metal dichalcogenides
Zhong Lin et al.
2D MATERIALS (2016)
Eriodictyol-induced anti-cancer and apoptotic effects in human hepatocellular carcinoma cells are associated with cell cycle arrest and modulation of apoptosis-related proteins
Fang Wang et al.
BANGLADESH JOURNAL OF PHARMACOLOGY (2016)
MTOR, PIK3C3, and autophagy: Signaling the beginning from the end
Michael J. Munson et al.
AUTOPHAGY (2015)
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
S. J. Thomas et al.
BRITISH JOURNAL OF CANCER (2015)
Defective Autophagosome Formation in p53-Null Colorectal Cancer Reinforces Crocin-Induced Apoptosis
Amr Amin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
Calin Cainap et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium
Jixiang Zhang et al.
MEDICAL ONCOLOGY (2015)
Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line
Akhilendra Kumar Maurya et al.
MOLECULAR BIOLOGY REPORTS (2015)
Baculovirus-Mediated miRNA Regulation to Suppress Hepatocellular Carcinoma Tumorigenicity and Metastasis
Chiu-Ling Chen et al.
MOLECULAR THERAPY (2015)
Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit
Chunjiang Wu et al.
MOLECULES (2015)
Baicalein Triggers Autophagy and Inhibits the Protein Kinase B/Mammalian Target of Rapamycin Pathway in Hepatocellular Carcinoma HepG2 Cells
Ya-Fang Wang et al.
PHYTOTHERAPY RESEARCH (2015)
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
Jia-Yuan Huang et al.
ONCOTARGET (2015)
Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
Matthias S. Matter et al.
JOURNAL OF HEPATOLOGY (2014)
Combination of Bevacizumab and Acyclic Retinoid Inhibits the Growth of Hepatocellular Carcinoma Xenografts
Masaya Kubota et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2014)
Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma
Imge Kunter et al.
ONCOLOGY REPORTS (2014)
S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells
Dandan Tong et al.
ONCOLOGY REPORTS (2014)
Versatile microRNA biogenesis in animals and their viruses
Mingyi Xie et al.
RNA BIOLOGY (2014)
Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling
Guangwen Shu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
STAT3 in hepatocellular carcinoma: new perspectives
Jasmin Svinka et al.
HEPATIC ONCOLOGY (2014)
Molecular mechanisms of luteolin-7-O-glucoside-induced growth inhibition on human liver cancer cells: G2/M cell cycle arrest and caspase-independent apoptotic signaling pathways
Yu-Jin Hwang et al.
BMB REPORTS (2013)
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
Han Chong Toh et al.
CANCER (2013)
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Riad Salem et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress
Lijuan Su et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
Angela Gauthier et al.
HEPATOLOGY RESEARCH (2013)
Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT
Min Xu et al.
HEPATOLOGY RESEARCH (2013)
Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation
Qiang Li et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial
Steven Robert Alberts et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Antiproliferative Effects of Crocin in HepG2 Cells by Telomerase Inhibition and hTERT Down-Regulation
Sakineh Kazemi Noureini et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents
Jianwen Yao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Beclin 1-mediated autophagy in hepatocellular carcinoma cells: Implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling
Meijuan Zou et al.
CELLULAR SIGNALLING (2012)
Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Richard S. Finn et al.
CLINICAL CANCER RESEARCH (2012)
Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Cody J. Peer et al.
CLINICAL CANCER RESEARCH (2012)
Targeting mTOR Pathways in Human Malignancies
Angelica Fasolo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling
Rong-Rui Liang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2012)
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses
Jean-Luc Raoul et al.
JOURNAL OF HEPATOLOGY (2012)
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma
Fumihiko Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
c-Met Represents a Potential Therapeutic Target for Personalized Treatment in Hepatocellular Carcinoma
Hanning You et al.
HEPATOLOGY (2011)
Saffron: A Potential Candidate for a Novel Anticancer Drug Against Hepatocellular Carcinoma
Amr Amin et al.
HEPATOLOGY (2011)
Intercellular Nanovesicle-Mediated microRNA Transfer: A Mechanism of Environmental Modulation of Hepatocellular Cancer Cell Growth
Takayuki Kogure et al.
HEPATOLOGY (2011)
Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
Bert H. O'Neil et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
Wei-Tien Tai et al.
JOURNAL OF HEPATOLOGY (2011)
Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
Kuen-Feng Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
Anne-Christine Piguet et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma
Chiara Braconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions
Ilias Mylonis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
Tongsen Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway
Hai-Tao Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
B. Viollet et al.
ACTA PHYSIOLOGICA (2009)
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Madlaina Breuleux et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Resveratrol inhibits tumor necrosis factor-α-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells
Haibo Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells
Masahito Shimizu et al.
CANCER LETTERS (2008)
Computer-aided drug discovery and development (CADDD):: In silico-chemico-biological approach
I. M. Kapetanovic
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Hung Huynh et al.
CLINICAL CANCER RESEARCH (2008)
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
Viraj J. Jasinghe et al.
JOURNAL OF HEPATOLOGY (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma
Sundaram Jagan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways
Tingfang Yi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
Melanie B. Thomas et al.
CANCER (2007)
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
Andrew X. Zhu et al.
CANCER (2007)
Hepatocellular carcinoma development in cirrhosis
Hiroaki Okuda
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2007)
A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins
T. Nishikawa et al.
JOURNAL OF HEPATOLOGY (2006)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC
DF Calvisi et al.
GASTROENTEROLOGY (2006)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma
Bu-Dong Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
A phospholipase c-dependent intracellular Ca2+ release pathway mediates the capsaicin-induced apoptosis in HepG2 human hepatoma cells
JA Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation
K Kato et al.
ONCOGENE (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
Design and discovery of small molecules targeting Raf-1 kinase
TB Lowinger et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation
MY Jung et al.
CANCER LETTERS (2001)
Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process
NJ Waterhouse et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
